课题基金 / 基金详情

IGF::OT::IGF SPECIAL STUDIES/ANALYSIS- CHEMICAL/BIOLOGICAL

IGF::OT::IGF SPECIAL STUDIES/ANALYSIS- CHEMICAL/BIOLOGICAL
IGF::OT::IGF 特殊研究/分析 - 化学/生物
批准号:
9161154
负责人:
ROBERT GIANNINI
金额:
$7.48万
依托单位:
--
依托单位国家:
美国
项目类别:
财政年份:
2015
资助国家:
美国
项目状态:
已结题
起止时间:
2015-06-30 至 2020-06-29

项目摘要

项目成果

ROBERT GIANNINI的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Chloramphencol Capsules at 250 mg strength for Clinical Use. The following composition was produced by PDS: Ingredient Quantity per Unit Chloramphenicol, USP Powder 1 255 mg Lactose, Anhydrous, NF 56.85 mg Sodium Lauryl Sulfate, NF 3.15 mg Total Powder Weight 2 315 mg Capsule, Pink Opaque #2 60 mg Gross weight 375 mg 1 2% overage added to formulation 2 Value derived from pre formulation work Except Controlled Room Temperature (20C to 25C), all other processing conditions will be usual pharmaceutical manufacturing operations. Active ingredient for this project will be provided by the NCI. It should be noted that the capsule color may vary depending on the available Capsule Shell.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
NEXT DTP-23-017, PRODUCTION OF 0.25MG OF AZATDC AND TDCYD CAPSULES
  • 批准号:
    10948447
  • 项目类别:
  • 资助金额:
    $6.62万
  • 财政年份:
    2023
  • 负责人:
    ROBERT GIANNINI
  • 依托单位:
NExT DTP-23-019 GMP PRODUCTION OF 40MG CAPSULES OF Z-ENDOXIFEN
  • 批准号:
    10948454
  • 项目类别:
  • 资助金额:
    $14.0万
  • 财政年份:
    2023
  • 负责人:
    ROBERT GIANNINI
  • 依托单位:
SOCIETAL IS A SMALL BUSINESS CONCERN FOR DOSAGE FORM DEVELOPMENT, MANUFACTURE, AND STABILITY STUDIES OF NCGC72
  • 批准号:
    10953952
  • 项目类别:
  • 资助金额:
    $18.29万
  • 财政年份:
    2023
  • 负责人:
    ROBERT GIANNINI
  • 依托单位:
PRODUCTION OF AMMONIUM TETRATHIOMOLIBDATE (ATTM) CAPSULES FOR USE IN CLINICAL TRIALS
  • 批准号:
    10710311
  • 项目类别:
  • 资助金额:
    $41.31万
  • 财政年份:
    2022
  • 负责人:
    ROBERT GIANNINI
  • 依托单位:
海外基金